BACKGROUND:Breast or chest-wall pain (BCP) is prevalent in 20%-50% of breast cancer survivors, and it affects quality of life (QOL). To determine the feasibility and potential efficacy of an exercise program to improve patient QOL and BCP, such a program was offered to breast cancer patients suffering from BCP. METHODS: The study enrolled 10 breast cancer patients with moderate-to-severe BCP at 3-6 months after completion of all adjuvant treatments. These patients participated in a 12-week comprehensive health improvement program (CHIP). Intensity was adjusted to reach 65%-85% of the patient's maximal heart rate. Before the CHIP and at 1 and 6 months after completion of the CHIP, QOL and pain were measured using questionnaires [European Organisation for Research and Treatment of Cancer Quality of Life core and breast cancer modules (QLQ-C30, -BR23) and the McGill Pain Questionnaire short form] completed by the patients. Results were compared with those from case-matched control subjects from another study at McGill University. RESULTS: After the CHIP, patients reported significant and clinically important improvements in QOL and symptoms. At 1 and 6 months post-CHIP, patients in the study felt, on average, better in overall QOL than did historical control subjects. CONCLUSIONS: Our study suggests that patients who experience chronic bcp may benefit from an exercise program. A randomized controlled trial is warranted.
RCT Entities:
BACKGROUND: Breast or chest-wall pain (BCP) is prevalent in 20%-50% of breast cancer survivors, and it affects quality of life (QOL). To determine the feasibility and potential efficacy of an exercise program to improve patient QOL and BCP, such a program was offered to breast cancerpatients suffering from BCP. METHODS: The study enrolled 10 breast cancerpatients with moderate-to-severe BCP at 3-6 months after completion of all adjuvant treatments. These patients participated in a 12-week comprehensive health improvement program (CHIP). Intensity was adjusted to reach 65%-85% of the patient's maximal heart rate. Before the CHIP and at 1 and 6 months after completion of the CHIP, QOL and pain were measured using questionnaires [European Organisation for Research and Treatment of Cancer Quality of Life core and breast cancer modules (QLQ-C30, -BR23) and the McGill Pain Questionnaire short form] completed by the patients. Results were compared with those from case-matched control subjects from another study at McGill University. RESULTS: After the CHIP, patients reported significant and clinically important improvements in QOL and symptoms. At 1 and 6 months post-CHIP, patients in the study felt, on average, better in overall QOL than did historical control subjects. CONCLUSIONS: Our study suggests that patients who experience chronic bcp may benefit from an exercise program. A randomized controlled trial is warranted.
Entities:
Keywords:
Breast cancer; chest wall; chronic; exercise; pain; quality of life; rehabilitation; survivorship
Authors: M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson Journal: J Clin Oncol Date: 1996-10 Impact factor: 44.544
Authors: J S Carpenter; M A Andrykowski; P Sloan; L Cunningham; M J Cordova; J L Studts; P C McGrath; D Sloan; D E Kenady Journal: J Clin Epidemiol Date: 1998-12 Impact factor: 6.437
Authors: Margaret L McNeely; Kristin Campbell; Maria Ospina; Brian H Rowe; Kelly Dabbs; Terry P Klassen; John Mackey; Kerry Courneya Journal: Cochrane Database Syst Rev Date: 2010-06-16
Authors: Orazio Caffo; Maurizio Amichetti; Antonella Ferro; Antonio Lucenti; Francesco Valduga; Enzo Galligioni Journal: Breast Cancer Res Treat Date: 2003-07 Impact factor: 4.872
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Patricia A Ganz; Lorna Kwan; Annette L Stanton; Janice L Krupnick; Julia H Rowland; Beth E Meyerowitz; Julienne E Bower; Thomas R Belin Journal: J Natl Cancer Inst Date: 2004-03-03 Impact factor: 13.506
Authors: Carien H G Beurskens; Caro J T van Uden; Luc J A Strobbe; Rob A B Oostendorp; Theo Wobbes Journal: BMC Cancer Date: 2007-08-30 Impact factor: 4.430
Authors: Catherine M Jankowski; Marcia G Ory; Daniela B Friedman; Andrea Dwyer; Sarah A Birken; Betsy Risendal Journal: J Cancer Surviv Date: 2014-08-08 Impact factor: 4.442
Authors: Adamu Ahmad Rufa'i; Wan Abdul Manan Wan Muda; Siew Hwa Yen; Aishah Knight Abd Shatar; Bhavaraju Venkata Krishna Murali; Shu Wen Tan Journal: BMJ Glob Health Date: 2016-07-26
Authors: Martina Ferioli; Giorgio Zauli; Alberto M Martelli; Marco Vitale; James A McCubrey; Simona Ultimo; Silvano Capitani; Luca M Neri Journal: Oncotarget Date: 2018-02-08